SHCBP1: A Protein with Potential as A Drug Target and Biomarker

Target Name: SHCBP1

NCBI ID: G79801

SHCBP1

SHCBP1: A Protein with Potential as A Drug Target and Biomarker

SHCBP1 (MGC26900) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and kidneys. It is a member of the superfamily of RNA-binding proteins, known as HITs (hierarchical interactions with RNA) , and is characterized by its ability to form double-stranded RNA structures.

SHCBP1 has been shown to play a role in a variety of physiological processes in the body, including cell signaling, gene regulation, and RNA homeostasis. It has also been linked to a number of diseases, including cancer, neurodegenerative diseases, and respiratory diseases.

One of the most promising aspects of SHCBP1 is its potential as a drug target. SHCBP1 has been shown to interact with a wide range of small molecules, including drugs that are currently being used to treat a variety of diseases. Additionally, SHCBP1 has been shown to be highly sensitive to changes in pH, which can make it an attractive target for drugs that alter cellular pH levels.

In addition to its potential as a drug target, SHCBP1 also has the potential as a biomarker for a variety of diseases. Its expression has been shown to be elevated in a number of diseases, including cancer, neurodegenerative diseases, and respiratory diseases. Additionally, SHCBP1 has been shown to have a strong correlation with a variety of biomarkers, including the social development index (ASI), which is a measure of cancer risk that is calculated based on a number of factors, including age, sex, and family history.

Overall, SHCBP1 is a protein that has the potential to be a drug target and a biomarker for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments for those diseases.

Protein Name: SHC Binding And Spindle Associated 1

Functions: May play a role in signaling pathways governing cellular proliferation, cell growth and differentiation. May be a component of a novel signaling pathway downstream of Shc. Acts as a positive regulator of FGF signaling in neural progenitor cells

The "SHCBP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SHCBP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets